일신바이오
Financials
Valuation Metrics
일신바이오's Market Cap is ₩441B. At end of 2025 it was ₩712B. Ranked #1794 of 2,405 in KR market (top 75%), #1097 of 1,627 on KOSDAQ (top 67%), #292 of 361 in Capital Goods (top 81%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 44.08B KRW | KR#1,794/2,405 Sec#292/361 |
| Revenue | 15.79B KRW | KR#2,195/2,405 Sec#338/361 |
| Net Income | 6.01B KRW | KR#1,142/2,405 Sec#185/361 |
| Total Assets | 68.58B KRW | KR#2,017/2,405 Sec#327/361 |
| Net Assets | 64.80B KRW | KR#1,736/2,405 Sec#282/361 |
| Employees | 37 | KR#2,140/2,405 Sec#324/361 |
| Value | ||
| P/E | 7.33x | KR#657/2,405 Sec#98/361 |
| P/B | 0.68x | KR#1,174/2,405 Sec#164/361 |
| PEG | 0.13x | KR#486/2,405 Sec#74/361 |
| P/S | 2.79x | KR#1,976/2,405 Sec#304/361 |
| EV/EBITDA | 8.48x | KR#556/2,405 Sec#80/361 |
| FCF Yield | 11.93% | KR#571/2,405 Sec#90/361 |
| Profitability | ||
| ROE | 9.28% | KR#669/2,405 Sec#112/361 |
| ROA | 8.77% | KR#364/2,405 Sec#56/361 |
| Op. Margin | 31.42% | KR#53/2,405 Sec#5/361 |
| Revenue Growth | 32.31% | KR#356/2,405 Sec#57/361 |
| Earnings Growth | 56.48% | KR#525/2,405 Sec#79/361 |
| Financial Health | ||
| Debt Ratio | 5.85% | KR#45/2,405 Sec#3/361 |
| Total Debt | 0 KRW | KR—/2,405 Sec—/361 |
| FCF | 5.26B KRW | KR#889/2,405 Sec#142/361 |
| Cash | 1.98B KRW | KR#2,240/2,405 Sec#341/361 |
| Net Debt/EBITDA | -0.40x | KR#518/2,405 Sec#62/361 |
| Dividend | ||
| Div. Yield | 1.00% | KR#1,139/2,405 Sec#169/361 |
| Div. Growth | 42.86% | KR#276/2,405 Sec#58/361 |
| Performance | ||
| 1Y Return | -31.81% | KR#1,511/2,405 Sec#221/361 |
| 1M Return | -3.11% | KR#543/2,405 Sec#50/361 |
| From 52W High | -51.48% | KR#1,237/2,405 Sec#145/361 |
| 1Y MDD | -53.40% | KR#1,106/2,405 Sec#135/361 |
| Trading | ||
| Volume | 12,377 shares | KR#1,747/2,405 Sec#295/361 |
| Trading Value | 12.3M KRW | KR#2,208/2,405 Sec#343/361 |
| Foreign Own. | 3.05% | KR#1,269/2,405 Sec#210/361 |
| Per Share | ||
| EPS | 136 KRW | KR#1,378/2,405 Sec#218/361 |
| BPS | 1,465 KRW | KR#2,206/2,405 Sec#344/361 |
Company Info
Established in 1988 and converted to a corporation in 1994, the company was listed on KOSDAQ in 2007 and changed its name to Ilshinbiobase in 2009. It specializes in bio-equipment, manufacturing, selling, and exporting research equipment like lyophilizers for biotechnology research and ultra-low temperature freezers, alongside large industrial lyophilizers. Leveraging vacuum, refrigeration, and control technologies, the company offers a diverse product lineup and pursues growth by developing high-performance automatic control systems and expanding global GMP-compliant models. Ilshinbio is headquartered in Dongducheon-si, Gyeonggi-do.